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A Retrospective Analysis of an Opiate Education and Naloxone Distribution Program 
The opioid epidemic is a problem that has crossed all ethnic, racial, and socioeconomic 
classes throughout the United States. More than 22 million Americans are using illicit drugs 
yearly and approximately 91% of those individuals have a substance use disorder related to 
alcohol and/or drugs. Millions of Americans have an opioid use disorder involving either illegal 
or prescription drugs. There has been a national increase in the nonmedical use of prescription 
drugs and evidence suggests that nonmedical opioid use progresses to heroin use (St. Marie et 
al., 2018). Heroin, illicit fentanyl, and other equivalents are readily available and less expensive 
(Skolnick & Volkow, 2016).  Therefore, local substance use disorder clinics need to have a 
policy and protocol in place to address the potential of an overdose, particularly at the initiation 
of treatment (Fairbairn, Coffin, & Walley, 2017).  
Educating clients and caregivers about naloxone (Narcan) administration may prevent 
opiate-related deaths. Evidence has shown that educating practitioners, first responders, and 
laypeople on overdose prevention using naloxone (Narcan) can decrease opiate-related death 
outcomes (Lambdin, Zibbell, Wheeler & Kral, 2018). With more substance use disorder clinics 
offering Opiate Education and Naloxone Distribution (OEND), more naloxone education 
opportunities are available to those most closely affected.  
Literature Review 
  Understanding the concepts, administration guidelines, practices, and policies related to 
substance use disorders is essential. Continued opiate use changes the neurologic pathways 
within the brain leading to the drug seeking, cravings, and vulnerability of relapse attributed to 
opioid dependence (Tahsili-Fahadan & Aston-Jones, 2010).  Substance use disorder (SUD) is a 
spectrum disorder, meaning that it ranges from mild to severe (MO-HOPE project, 2016). SUD 
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is a completely preventable brain disease that can be diagnosed and treated, and from which 
people recover. Some pharmaceutical companies believe that resources, both human and 
monetary, are better utilized in areas (Skolnick & Volkow, 2016).  
By gaining an understanding of the presentation and treatment of opiate use disorder, 
health professionals are better able to develop a plan to address the needs of an individual during 
the treatment process (Beauchamp, Winstanley, Ryan & Lyons, 2014). Hallmark signs of 
addiction include continuously violating established limits or continued substance abuse 
regardless of negative consequences (MO-HOPE Project, 2016). The MO-HOPE Project (2016) 
defines tolerance as requiring more and more of “something” to achieve the same feeling and 
withdrawal as experiencing negative symptoms when a drug is suddenly stopped (e.g., flu-like 
symptoms-nausea and vomiting diarrhea, chills, increased heart rate lethargy, fatigue, etc.). 
When tolerance is low, even a small amount of an opioid can lead to an overdose. Most people 
seek treatment inpatient and outpatient clinics or hospitals.  
There are a variety of medications available for SUD. Determining the proper treatment 
is individualized and should be developed in collaboration with a practitioner to increase 
compliance. The setting in which an individual is being treated, inpatient or outpatient, should 
also be considered. OEND programs are becoming a mainstay in the prevention of opiate-related 
deaths (Fairbairn, Coffin, & Walley, 2017). These programs can be implemented within the 
community to help educate and prepare citizens to help reduce the number of opiate-related 
deaths.    
Project Methods 
 The evaluation of naloxone distribution at a Midwestern substance use disorder clinic 
involved the retrospective analysis of data regarding the delivery and administration of naloxone. 
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The project focused on N = 48 individuals in the initial treatment phase for opiate use disorder 
with methadone who received naloxone from April to January of 2017. The phases are centered 
on when the client comes to the clinic to receive methadone. Clients are required to attend 
groups and individual counseling sessions. The counselors at the clinic evaluated potential 
clients during personal counseling sessions to determine clients who were appropriate candidates 
for naloxone education and distribution.   
The participants who received naloxone were chosen and educated by the clinics 
counseling staff based on the OEND protocol established by the Missouri Opioid Heroin 
Prevention and Education (MO-HOPE) project. The trained counselors followed the MO-HOPE 
project protocol to discuss the acute risks factors of opiate overdose, explained the signs of 
overdose, appropriate rescue response, proper administration of naloxone, and tips to prevent an 
opiate-related overdose.  
The goal was to evaluate clients who had access to naloxone and document how many 
would use the naloxone in the event of an opiate-related overdose because this can increase 
compliance with methadone treatment. Data was collected focused on information that 
determined the client's phase throughout the project timeline, if clients transitioned, if they 
regressed to a previous phase, or if they were terminated from treatment. Additional data 
collection included the amount of naloxone dispensed and the number of clients who used 
naloxone during data analysis. Demographic information including gender, ethnicity, age, and 
employment status was collected to gain a better understanding of the studied client population.  
 The Southern Illinois University at Edwardsville Institutional Review Board (SIUE IRB) 
approved this project. The MO-HOPE project provided the intranasal naloxone to the substance 
use disorder clinic for distribution to clients.  
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Evaluation 
 With a limited supply of naloxone, the counseling staff determined that N = 48 clients 
warranted prompt education on naloxone administration and received naloxone during the 
counseling session. There were 77% Caucasians (n = 37), 19% African Americans (n = 9), and 
4% Hispanics (n = 2) who received naloxone. Most clients who received naloxone were between 
the ages of 31 and 50 (62.5%). Most clients, 62.5% (n = 30) were unemployed who received 
naloxone. Approximately 23% (n = 11) brought a caregiver to the education. Of these 48 clients, 
15% (n = 7) required replacement naloxone.  Two clients requested naloxone replacements due 
to extenuating circumstances (e.g., extreme cold temperature for naloxone storage and naloxone 
left in an impounded vehicle). Five administered the naloxone for an opiate-related overdose. 
There were 27.08% (n = 13) men and 72.916% (n = 35) women who received naloxone.  
Impact on Practice  
The responsibility to educate and inform the community rests on the interdisciplinary 
team of healthcare providers within the communities to provide this valued resource to this 
patient population. The substance use disorder clinic viewed the clients’ use of the naloxone as a 
positive outcome. The clients’ use of the naloxone became a counseling point for these clients. 
Additionally, the clinic found a permanent naloxone supply. Funds from the Substance Abuse 
and Mental Health Services Administration (SAMHSA) opioid State Targeted Response (STR) 
grants, will allow the clinic to have a sustainable naloxone supply with these funds. The clinic 
currently has 105 eligible clients.  
Conclusions 
Studies have shown that community OEND programs can have a positive impact on the 
communities serviced. Equally as important is that people are aware such resources are available. 
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Programs like OEND are needed within areas with high incidence of opiate-related deaths 
(Lambdin et al., 2018; Jones, Roux, Stancliff, Matthews, & Comer, 2014).  With the 
implementation of more substance use disorder clinics offering OEND, more people will have 
access to both the knowledge of naloxone, how to administer the medication, and can better 
address the underlying causes for opiate use disorder during treatment. More information is 
needed on why perspectives of the clients towards naloxone and its use. Moreover, the clinic 
may consider another way to track naloxone distribution, if or when utilized, and in what manner 
was naloxone used. OEND has a positive impact on communities. With education and access to 
naloxone, the potential to save more and prevent opiate-related deaths is there.      
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